Breast reconstruction using a staged nipple-sparing mastectomy following mastopexy or reduction.

Plastic and reconstructive surgery 2012 Vol.129(3) p. 572-581

Spear SL, Rottman SJ, Seiboth LA, Hannan CM

관련 도메인

Abstract

[BACKGROUND] To address those patients who do not meet anatomical criteria for nipple-sparing mastectomy, the authors use a staged approach: (1) mastopexy or breast reduction, (2) nipple-sparing mastectomy through the mastopexy incisions after a minimum of 3 to 4 weeks, and (3) the final reconstruction.

[METHODS] Fifteen patients underwent nipple-sparing mastectomy at Georgetown University Hospital between 2007 and 2010 after planned or unrelated mastopexy or reduction. An institutional review board-approved retrospective chart review recorded demographic information and outcomes such as skin necrosis and device failure.

[RESULTS] Fifteen patients (24 breasts) underwent nipple-sparing mastectomy after mastopexy or reduction with an average follow-up of 13 months. The staged procedure was planned in 10 patients [19 breasts (79 percent)] and unplanned, or coincidental, in five [five breasts (21 percent)]. The mastectomy was prophylactic in 17 breasts (71 percent) and therapeutic in seven (29 percent). Four of the 24 operated breasts (17 percent) experienced a complication. Two patients [two breasts (8 percent)] developed skin flap necrosis. Two patients [three breasts (13 percent)] developed minimal partial nipple-areola complex necrosis. One patient [one breast (4 percent)] had an expander explanted for infection related to skin flap necrosis. Fourteen patients [23 breasts (96 percent)] successfully recovered following nipple-sparing mastectomy and prior mastopexy or reduction without residual effects of nipple-areola complex or skin flap necrosis.

[CONCLUSIONS] The authors are comfortable offering the staged approach to nipple-sparing mastectomy to patients with moderately large or ptotic breasts. It may not be suitable for the very large or ptotic breast.

[CLINICAL QUESTION/LEVEL OF EVIDENCE] Therapeutic, IV.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 mastopexy 유방성형술 dict 6
해부 breast 유방 dict 4
시술 flap 피판재건술 dict 3
합병증 flap necrosis 괴사 dict 3
시술 breast reduction 유방성형술 dict 1
해부 skin scispacy 1
해부 breasts scispacy 1
해부 nipple-areola scispacy 1
합병증 infection 감염 dict 1
합병증 skin necrosis 괴사 dict 1
합병증 necrosis 괴사 dict 1
합병증 nipple-sparing mastectomy scispacy 1
합병증 mastopexy incisions scispacy 1
합병증 skin flap scispacy 1
약물 [BACKGROUND] scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 breasts C0006141
Breast
scispacy 1
질환 ptotic breasts scispacy 1
질환 nipple-sparing mastectomy scispacy 1
질환 breast (4 percent scispacy 1
질환 ptotic breast scispacy 1
기타 patients scispacy 1
기타 patient scispacy 1

MeSH Terms

Adult; Aged; Breast Neoplasms; Female; Humans; Mammaplasty; Mastectomy; Middle Aged; Nipples; Retrospective Studies

📑 인용 관계

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문